Tag: yttrium 90

ebrahim s delpassand md facnm

FDA Approves Amendment for PRRT Clinical Trial in Texas

August 2, 2012

BREAKING NEWS:  The Food and Drug Administration (FDA) has just approved the RadioIsotope Therapy of America (RITA) Foundation’s amendment to the Investigational New Drug (IND) protocol for intra-hepatic artery administration of Lu-177 Octreotate

READ MORE
y 90 radiomicrosphere therapy workshop banner2

Y-90 Radiomicrosphere Therapy Workshop To Be Offered in Florida

May 12, 2010

Carcinoid and neuroendocrine cancer patients interested in learning more about Y-90 radiomicrosphere therapy can join physicians, scientists, and technologists for a workshop being presented by “Advances in Minimally Invasive Treatments” International

READ MORE

Canadian Report Card on Cancer Features Carcinoid and Neuroendocrine Cancers

March 26, 2010

An article by Maureen Coleman, President of the Carcinoid Neuro-Endocrine Tumour Society (CNETS) Canada www.cnetscanada.org, on carcinoid and neuroendocrine cancers is featured in the rare cancers section of the 2009-2010 Report Card on Cancer

READ MORE